Clinical Trial 42474

Berlin, NJ 08009


Summary:

Evaluate the safety and tolerability of investigational study drug administered by subcutaneous (SQ) injection to adults with moderate to severe, active Crohn’s disease (CD) who have failed prior treatment with anti-tumor necrosis factor alpha (TNFα) agen.


Qualified Participants Must:

• Male or Females ages 18 to 65 years old
• Has diagnosis of CD
• Speak English fluently
• Moderate to severe active CD


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.